News NICE to launch ‘Office for Market Access’ NICE is to establish a new Office for Market Access to help life sciences companies prepare for its cost effectiveness appraisals and improve their chances of gaining a 'yes'.
News Roche challenges NICE on Kadcyla and ignoring pricing deal Row over breast cancer drug Kadcyla continues
Views & Analysis Who influences NICE technology appraisals? In the world of pharmaceuticals everyone seems to have heard of the National Institute for Health and Care Excellence (NICE).
Views & Analysis Pharma gets social: did digital opinion leaders shape NICE g... Digital Opinion Leaders as activists in healthcare decision making.
News Hengrui gets world-first okay for platelet drug hetrombopag Hengrui's oral TPO agonist, hetrombopag, is the first in the class to be approved for thrombocytopenia caused by chemotherapy for solid tumours.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.